{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T18:17:43Z","timestamp":1770142663982,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T00:00:00Z","timestamp":1675468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Liver Research"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.livres.2023.02.001","type":"journal-article","created":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T04:42:04Z","timestamp":1675917724000},"page":"71-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Direct-acting antivirals sofosbuvir and daclatasvir attenuate carbon tetrachloride-induced liver fibrosis in mice"],"prefix":"10.1016","volume":"7","author":[{"given":"Mayadah M.","family":"Abdelsalam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nageh","family":"El-Mahdy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabry","family":"Abou-Saif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.livres.2023.02.001_bib1","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.4254\/wjh.v7.i8.1020","article-title":"Hepatocellular carcinoma: from diagnosis to treatment","volume":"7","author":"Waghray","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.livres.2023.02.001_bib2","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/MCG.0b013e3182872f29","article-title":"Epidemiology of hepatocellular carcinoma: consider the population","volume":"47Suppl(0)","author":"Mittal","year":"2013","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.livres.2023.02.001_bib3","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.3390\/ijms20071723","article-title":"The role of fibrosis and liver-associated fibroblasts in the pathogenesis of hepatocellular carcinoma","volume":"20","author":"Baglieri","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.livres.2023.02.001_bib4","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00204-015-1543-4","article-title":"Experimental models of liver fibrosis","volume":"90","author":"Yanguas","year":"2016","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.livres.2023.02.001_bib5","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00441-006-0334-x","article-title":"Administration of fibroblast growth factor 2 in combination with bone marrow transplantation synergistically improves carbon-tetrachloride-induced liver fibrosis in mice","volume":"327","author":"Ishikawa","year":"2007","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.livres.2023.02.001_bib6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s40139-015-0093-z","article-title":"TNF\u03b1 in liver fibrosis","volume":"3","author":"Yang","year":"2015","journal-title":"Curr Pathobiol Rep"},{"key":"10.1016\/j.livres.2023.02.001_bib7","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1053\/j.gastro.2004.09.014","article-title":"Hepatocellular carcinoma in cirrhosis: incidence and risk factors","volume":"127","author":"Fattovich","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2023.02.001_bib8","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/hep.27654","article-title":"High liver fibrosis index FIB-4 is highly predictive of hepatocellular carcinoma in chronic hepatitis B carriers","volume":"61","author":"Suh","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2023.02.001_bib9","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1872-034X.2011.00846.x","article-title":"Liver stiffness measured by transient elastography is a predictor of hepatocellular carcinoma development in viral hepatitis","volume":"41","author":"Akima","year":"2011","journal-title":"Hepatol Res"},{"key":"10.1016\/j.livres.2023.02.001_bib10","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/bjc.2013.352","article-title":"Impact of liver fibrosis on prognosis following liver resection for hepatitis B-associated hepatocellular carcinoma","volume":"109","author":"Wang","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.livres.2023.02.001_bib11","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1309\/AJCP86PPBNGOHNNL","article-title":"Peritumoral activated hepatic stellate cells predict poor clinical outcome in hepatocellular carcinoma after curative resection","volume":"131","author":"Ju","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.livres.2023.02.001_bib12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1053\/j.seminoncol.2014.12.023","article-title":"Hepatitis C virus infection, antiviral therapy, and risk of hepatocellular carcinoma","volume":"42","author":"Hsu","year":"2015","journal-title":"Semin Oncol"},{"key":"10.1016\/j.livres.2023.02.001_bib13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.coviro.2017.03.017","article-title":"Direct-acting antivirals: the endgame for hepatitis C?","volume":"24","author":"D\u2019Ambrosio","year":"2017","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.livres.2023.02.001_bib14","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra1001683","article-title":"Hepatocellular carcinoma","volume":"365","author":"El-Serag","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.livres.2023.02.001_bib15","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.livres.2023.02.001_bib16","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.cgh.2009.11.018","article-title":"A\u00a0sustained viral response is associated with reduced liver-related morbidity and mortality in patients with hepatitis C virus","volume":"8","author":"Singal","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2023.02.001_bib17","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1002\/hep.28473","article-title":"Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: a randomized phase III study (ALLY-3+)","volume":"63","author":"Leroy","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2023.02.001_bib18","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jhep.2016.04.008","article-title":"Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy","volume":"65","author":"Reig","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2023.02.001_bib19","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jhep.2016.06.015","article-title":"Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals","volume":"65","author":"Conti","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2023.02.001_bib20","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jhep.2009.09.008","article-title":"A\u00a0novel model of CCl4-induced cirrhosis with ascites in the mouse","volume":"51","author":"Domenicali","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2023.02.001_bib21","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1093\/infdis\/jiw437","article-title":"Protease inhibitor resistance remains even after mutant strains become undetectable by deep sequencing","volume":"214","author":"Kan","year":"2016","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.livres.2023.02.001_bib22","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s00535-015-1108-6","article-title":"Emergence of hepatitis C virus NS5A L31V plus Y93H variant upon treatment failure of daclatasvir and asunaprevir is relatively resistant to ledipasvir and NS5B polymerase nucleotide inhibitor GS-558093 in human hepatocyte chimeric mice","volume":"50","author":"Kai","year":"2015","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.livres.2023.02.001_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/srep41660","article-title":"Baseline quasispecies selection and novel mutations contribute to emerging resistance-associated substitutions in hepatitis C virus after direct-acting antiviral treatment","volume":"7","author":"Kai","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.livres.2023.02.001_bib24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/ajcp\/28.1.56","article-title":"A\u00a0colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases","volume":"28","author":"Reitman","year":"1957","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.livres.2023.02.001_bib25","doi-asserted-by":"crossref","first-page":"9163","DOI":"10.1038\/s41598-018-27427-9","article-title":"Comparison of two protocols of carbon tetrachloride-induced cirrhosis in rats - improving yield and reproducibility","volume":"8","author":"Fortea","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.livres.2023.02.001_bib26","doi-asserted-by":"crossref","first-page":"E3297","DOI":"10.1073\/pnas.1400062111","article-title":"Origin of myofibroblasts in the fibrotic liver in mice","volume":"111","author":"Iwaisako","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.livres.2023.02.001_bib27","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1016\/j.fct.2012.07.053","article-title":"Methyl helicterate protects against CCl4-induced liver injury in rats by inhibiting oxidative stress, NF-\u03baB activation, Fas\/FasL pathway and cytochrome P4502E1 level","volume":"50","author":"Lin","year":"2012","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.livres.2023.02.001_bib28","doi-asserted-by":"crossref","first-page":"696383","DOI":"10.1155\/2014\/696383","article-title":"Diethylcarbamazine reduces chronic inflammation and fibrosis in carbon tetrachloride- (CCl4-) induced liver injury in mice","volume":"2014","author":"Rocha","year":"2014","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.livres.2023.02.001_bib29","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1177\/0960327120937048","article-title":"Crocin attenuates CCl4-induced liver fibrosis via PPAR-\u03b3 mediated modulation of inflammation and fibrogenesis in rats","volume":"39","author":"Chhimwal","year":"2020","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.livres.2023.02.001_bib30","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/labinvest.2008.91","article-title":"Activation of hepatic stellate cells is associated with cytokine expression in thioacetamide-induced hepatic fibrosis in mice","volume":"88","author":"Salguero Palacios","year":"2008","journal-title":"Lab Invest"},{"key":"10.1016\/j.livres.2023.02.001_bib31","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2613.2008.00597.x","article-title":"Comparison of three research models of portal hypertension in mice: macroscopic, histological and portal pressure evaluation","volume":"89","author":"Geerts","year":"2008","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.livres.2023.02.001_bib32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-230X-10-79","article-title":"Mouse model of carbon tetrachloride induced liver fibrosis: histopathological changes and expression of CD133 and epidermal growth factor","volume":"10","author":"Fujii","year":"2010","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.livres.2023.02.001_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/srep35426","article-title":"Collapsed reticular network and its possible mechanism during the initiation and\/or progression of hepatic fibrosis","volume":"6","author":"Wen","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.livres.2023.02.001_bib34","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s004180000150","article-title":"Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat","volume":"113","author":"Knittel","year":"2000","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.livres.2023.02.001_bib35","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2174\/1874467213666200116114919","article-title":"Daclatasvir and sofosbuvir mitigate hepatic fibrosis through downregulation of TNF-\u03b1\/NF-\u03baB signaling pathway","volume":"13","author":"Zakaria","year":"2020","journal-title":"Curr Mol Pharmacol"},{"key":"10.1016\/j.livres.2023.02.001_bib36","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.dld.2015.09.015","article-title":"Early changes in dynamic biomarkers of liver fibrosis in hepatitis C virus-infected patients treated with sofosbuvir","volume":"48","author":"Bernuth","year":"2016","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.livres.2023.02.001_bib37","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12985-018-1066-8","article-title":"Satisfactory virological response and fibrosis improvement of sofosbuvir-based regimens for Chinese patients with hepatitis C virus genotype 3 infection: results of a real-world cohort study","volume":"15","author":"Tao","year":"2018","journal-title":"Virol J"},{"key":"10.1016\/j.livres.2023.02.001_bib38","doi-asserted-by":"crossref","first-page":"175","DOI":"10.5114\/ceh.2018.78121","article-title":"Hepatic effect of sofosbuvir and daclatasvir in thioacetamide-induced liver injury in rats","volume":"4","author":"Ibrahim","year":"2018","journal-title":"Clin Exp Hepatol"},{"key":"10.1016\/j.livres.2023.02.001_bib39","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.bpg.2011.02.004","article-title":"Animal models for the study of hepatic fibrosis","volume":"25","author":"Starkel","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.livres.2023.02.001_bib40","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s40139-014-0050-2","article-title":"Mouse models of liver fibrosis mimic human liver fibrosis of different etiologies","volume":"2","author":"Mart\u00ednez","year":"2014","journal-title":"Curr Pathobiol Rep"},{"key":"10.1016\/j.livres.2023.02.001_bib41","doi-asserted-by":"crossref","first-page":"858","DOI":"10.4254\/wjh.v8.i20.858","article-title":"Hepatitis C virus cures after direct acting antiviral-related drug-induced liver injury: case report","volume":"8","author":"Hasin","year":"2016","journal-title":"World J Hepatol"},{"key":"10.1016\/j.livres.2023.02.001_bib42","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1002\/jmv.25557","article-title":"Hepatotoxicity and virological breakthrough of HCV following treatment with sofosbuvir, daclatasvir, and ribavirin in patients previously treated for tuberculosis","volume":"91","author":"Wahid","year":"2019","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.livres.2023.02.001_bib43","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jhep.2015.07.041","article-title":"Liver toxicity associated with sofosbuvir, an NS5A inhibitor and ribavirin use","volume":"64","author":"Dyson","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2023.02.001_bib44","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/hep.27559","article-title":"Drug-induced immunoallergic hepatitis during combination therapy with daclatasvir and asunaprevir","volume":"61","author":"Fujii","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2023.02.001_bib45","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/j.gastro.2015.03.004","article-title":"Successful interferon-free therapy of chronic hepatitis C virus infection normalizes natural killer cell function","volume":"149","author":"Serti","year":"2015","journal-title":"Gastroenterology"}],"container-title":["Liver Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568423000028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568423000028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T14:46:44Z","timestamp":1762872404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2542568423000028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2542568423000028"],"URL":"https:\/\/doi.org\/10.1016\/j.livres.2023.02.001","relation":{},"ISSN":["2542-5684"],"issn-type":[{"value":"2542-5684","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct-acting antivirals sofosbuvir and daclatasvir attenuate carbon tetrachloride-induced liver fibrosis in mice","name":"articletitle","label":"Article Title"},{"value":"Liver Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.livres.2023.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Third Affiliated Hospital of Sun Yat-sen University. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}